Research Archives | Psychedelics Today https://www.psychedelicstoday.com/post_tags/research/ Education and Training for Clinicians and Beyond Thu, 20 Jun 2024 18:21:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.1.1 https://psychedelicstoday.com/wp-content/uploads/2022/10/PSY_001-Psychedelics-Logo_v1.2_Spore-Gradient-100x100.png Research Archives | Psychedelics Today https://www.psychedelicstoday.com/post_tags/research/ 32 32 Expanding Psychedelic Clinical Trials to LGBTQ+ Populations https://psychedelicstoday.com/2024/06/20/expanding-psychedelic-clinical-trials-to-lgbtq-populations/ https://psychedelicstoday.com/2024/06/20/expanding-psychedelic-clinical-trials-to-lgbtq-populations/#respond Thu, 20 Jun 2024 18:21:09 +0000 https://psychedelicstoday.com/?p=24174 Explore how expanding psychedelic clinical trials to include LGBTQ+ populations can address mental health disparities and foster inclusivity. This article underscores the urgent need for research that encompasses unique minority stressors, aiming for equitable and effective mental health interventions.

The post Expanding Psychedelic Clinical Trials to LGBTQ+ Populations appeared first on Psychedelics Today.

]]> https://psychedelicstoday.com/2024/06/20/expanding-psychedelic-clinical-trials-to-lgbtq-populations/feed/ 0 An Inside Look at the FDA and Early Drug Development https://psychedelicstoday.com/2024/06/18/an-inside-look-at-the-fda-and-early-drug-development/ https://psychedelicstoday.com/2024/06/18/an-inside-look-at-the-fda-and-early-drug-development/#respond Tue, 18 Jun 2024 17:50:58 +0000 https://psychedelicstoday.com/?p=24148 In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA. With Lykos Therapeutics working towards FDA approval of MDMA-assisted psychotherapy for PTSD, ICER (Institute for Clinical and Economic Review) recently published its draft evidence report, concluding that they couldn’t endorse […]

The post An Inside Look at the FDA and Early Drug Development appeared first on Psychedelics Today.

]]> https://psychedelicstoday.com/2024/06/18/an-inside-look-at-the-fda-and-early-drug-development/feed/ 0 Long COVID and Psychedelics https://psychedelicstoday.com/2024/05/31/long-covid-and-psychedelics/ https://psychedelicstoday.com/2024/05/31/long-covid-and-psychedelics/#respond Fri, 31 May 2024 14:24:27 +0000 https://psychedelicstoday.com/?p=23641 In this episode, special guest host Court Wing interviews Monica Verduzco-Gutierrez, MD: professor and chair of rehabilitation medicine at UT Health San Antonio; Joel Castellanos, MD: co-founder and associate medical director of the Center for Psychedelic Research at UC San Diego; and MaryAnn Welke Lesage: a long COVID survivor who reports experiencing drastic improvement in […]

The post Long COVID and Psychedelics appeared first on Psychedelics Today.

]]> https://psychedelicstoday.com/2024/05/31/long-covid-and-psychedelics/feed/ 0 RIPPLES of Hope: Psychedelics as a Tool for Peacebuilding and Collective Healing https://psychedelicstoday.com/2024/05/14/ripples-of-hope-psychedelics-as-a-tool-for-peacebuilding-and-collective-healing/ Tue, 14 May 2024 17:51:07 +0000 https://psychedelicstoday.com/?p=23224 In this episode, David interviews Sami Awad: Palestinian peace and nonviolent activist and founder of Holy Land Trust in Bethlehem; and Leor Roseman, Ph.D.: Israeli neuroscientist, researcher, and senior lecturer at the University of Exeter. They talk about Roseman’s 2021 paper, “Relational Processes in Ayahuasca Groups of Palestinians and Israelis,” which looked at what happened […]

The post RIPPLES of Hope: Psychedelics as a Tool for Peacebuilding and Collective Healing appeared first on Psychedelics Today.

]]> Unlocking Creativity: How Psychedelics Are Influencing Modern Design https://psychedelicstoday.com/2024/05/14/unlocking-creativity-how-psychedelics-are-influencing-modern-design/ Tue, 14 May 2024 14:34:03 +0000 https://psychedelicstoday.com/?p=23686 It’s no secret that psychedelics and creativity are intrinsically linked. If you look around, you won’t have to go very far to find psychedelic-inspired byproducts from visionary figures whose work has changed the world, from Yoko Ono, to Aldous Huxley, to Steve Jobs. While psychedelics’ impact on art is well-documented, the psychedelic influence on design […]

The post Unlocking Creativity: How Psychedelics Are Influencing Modern Design appeared first on Psychedelics Today.

]]> The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family Dynamics https://psychedelicstoday.com/2024/05/10/the-other-side-of-veteran-healing-secondary-ptsd-and-post-retreat-family-dynamics/ Fri, 10 May 2024 17:25:54 +0000 https://psychedelicstoday.com/?p=23653 In this episode, Joe interviews two members of the Heroic Hearts Project team: Director of Donor Development and founder of The Hope Project, Allison Wilson; and Director of Research and founder of Hystelica, Dr. Grace Blest-Hopley. They discuss how The Hope Project – a nonprofit that supports spouses of veterans, Gold Star Wives, and female […]

The post The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family Dynamics appeared first on Psychedelics Today.

]]> Early Research, Psychedelics in Palliative Care, and the Intersection of Science and the Sacred https://psychedelicstoday.com/2024/05/07/early-research-psychedelics-in-palliative-care-and-the-intersection-of-science-and-the-sacred/ Tue, 07 May 2024 17:08:12 +0000 https://psychedelicstoday.com/?p=23625 In this episode, Joe and Kyle interview William Richards, STM, Ph.D.: senior advisor at Sunstone Therapies, psychologist at the Center for Psychedelic and Consciousness Research at the Johns Hopkins School of Medicine, contributor to Vital, and author of Sacred Knowledge: Psychedelics & Religious Experiences. He talks about the first time he experienced psilocybin in a […]

The post Early Research, Psychedelics in Palliative Care, and the Intersection of Science and the Sacred appeared first on Psychedelics Today.

]]> Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality https://psychedelicstoday.com/2024/05/01/psychedelics-and-pregnancy/ Wed, 01 May 2024 19:50:01 +0000 https://psychedelicstoday.com/?p=9709 Psychedelics and pregnancy is a highly controversial and often unspoken topic. But beyond the stigma, what does the research, law and culture say?

The post Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality appeared first on Psychedelics Today.

]]> The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence https://psychedelicstoday.com/2024/04/19/the-microdosing-effect-connecting-the-dots-between-anecdote-and-evidence/ Fri, 19 Apr 2024 18:15:18 +0000 https://psychedelicstoday.com/?p=23361 In 2024, the discourse around the effects of microdosing psychedelics is deeply polarized. Positioned at opposite ends of the conversation are microdosing evangelists who swear by its benefits and skeptical scientists demanding more empirical evidence. Ask whether it ‘works,’ and you’ll receive an emphatic ‘yes’ from believers or an all-but-certain ‘no’ from doubters, highlighting a […]

The post The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence appeared first on Psychedelics Today.

]]> Shulgin Farm and the Future of Psychedelic Drug Development https://psychedelicstoday.com/2024/04/02/pt500-paul-f-daley-ph-d/ Tue, 02 Apr 2024 17:07:50 +0000 https://psychedelicstoday.com/?p=23009 In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. He is now the co-founder, Chief Science Officer, and Director of Analytical Science at the […]

The post Shulgin Farm and the Future of Psychedelic Drug Development appeared first on Psychedelics Today.

]]> PT490 – Plasticity, the Role of Set and Setting, and the Influence of Psychedelics https://psychedelicstoday.com/2024/02/27/pt490-dr-robin-carhart-harris/ Tue, 27 Feb 2024 17:49:08 +0000 https://psychedelicstoday.com/?p=22476 In this episode, Joe interviews Dr. Robin Carhart-Harris: founder and head of the Centre for Psychedelic Research at Imperial College London, founding director of the Neuroscape Psychedelics Division at University of California, San Francisco (UCSF), and founder of the Carhart-Harris Lab. A legendary researcher, he talks about his psychedelic origins: studying Freud, Jung, and eventually […]

The post PT490 – Plasticity, the Role of Set and Setting, and the Influence of Psychedelics appeared first on Psychedelics Today.

]]> PT483 – Traumatic Brain Injuries, the Gut Microbiome, and the Potential of Psychedelics as Anti-Inflammatory Agents https://psychedelicstoday.com/2024/02/02/pt483-dr-kate-pate/ Fri, 02 Feb 2024 18:53:35 +0000 https://psychedelicstoday.com/?p=22277 In this episode, Joe interviews Dr. Kate Pate: Ph.D. neurophysiologist; Founder and CEO of Coruna Medical; founding board member of the Psychedelic Medicine Association; and Founder of The Way Back, a company that will provide education and coaching services related to military, veteran, and first responder health – often in wilderness settings. She talks about […]

The post PT483 – Traumatic Brain Injuries, the Gut Microbiome, and the Potential of Psychedelics as Anti-Inflammatory Agents appeared first on Psychedelics Today.

]]> Gender Challenges in Psychedelic Retreats and Clinical Settings https://psychedelicstoday.com/2024/01/03/gender-challenges-in-psychedelic-retreats-and-clinical-settings/ Wed, 03 Jan 2024 14:39:31 +0000 https://psychedelicstoday.com/?p=21992 Do women respond differently to psychedelics than men? And, if so, how are their needs different when approaching these powerful substances? While crucial research is still limited to help us understand how and why the psychedelic experience might vary vastly among genders, the rise of female-only retreats, clinical settings, and thoughtfully designed psychedelic products and […]

The post Gender Challenges in Psychedelic Retreats and Clinical Settings appeared first on Psychedelics Today.

]]> PT471 – The Evolution of LSD Psychotherapy, the Power of Breathwork, and Why We Should be Taking Archetypal Astrology More Seriously https://psychedelicstoday.com/2023/12/22/pt471-stanislav-brigitte-grof/ Fri, 22 Dec 2023 18:37:36 +0000 https://psychedelicstoday.com/?p=21851 In this episode, Joe and Kyle are honored to welcome back Stanislav and Brigitte Grof: Stan being the person who kickstarted their interest in non-ordinary states of consciousness, breathwork, and this podcast; and Brigitte: his other half, co-creator of Grof® Legacy Training, and support system (and often, voice) since his stroke a few years back. […]

The post PT471 – The Evolution of LSD Psychotherapy, the Power of Breathwork, and Why We Should be Taking Archetypal Astrology More Seriously appeared first on Psychedelics Today.

]]> PT464 – Bodywork, Somatic Literacy, and Understanding Trauma: The Mind and Body Connection https://psychedelicstoday.com/2023/11/28/pt464-bessel-van-der-kolk-md/ Tue, 28 Nov 2023 18:27:58 +0000 https://psychedelicstoday.com/?p=21621 In this episode, Kyle interviews Bessel van der Kolk, MD: pioneer clinician, researcher, and educator on traumatic stress; Founder of the Trauma Research Foundation; Professor of Psychiatry at Boston University Medical School; Principal Investigator of the Boston site of MAPS’ MDMA-assisted psychotherapy study; and author of the #1 New York Times Science best seller, The […]

The post PT464 – Bodywork, Somatic Literacy, and Understanding Trauma: The Mind and Body Connection appeared first on Psychedelics Today.

]]> PT462 – Touch Therapy, Wearable Technology, and Treating Trauma with Safety https://psychedelicstoday.com/2023/11/21/pt462-dr-dave-rabin-md-ph-d/ Tue, 21 Nov 2023 16:45:56 +0000 https://psychedelicstoday.com/?p=21475 In this episode, Joe interviews neuroscientist, board-certified psychiatrist, health tech entrepreneur, inventor, and Co-Founder & Chief Medical Officer at Apollo Neuro: Dr. Dave Rabin, MD, Ph.D. He talks about his path to psychiatry; his realization that trauma and chronic stress were primary themes at the root of most mental illness; and the creation, research and […]

The post PT462 – Touch Therapy, Wearable Technology, and Treating Trauma with Safety appeared first on Psychedelics Today.

]]> PT458 – When Science, Society, and Policy Collide https://psychedelicstoday.com/2023/11/07/pt458-imran-khan/ Tue, 07 Nov 2023 17:25:56 +0000 https://psychedelicstoday.com/?p=21289 In this episode, Joe interviews Imran Khan: Executive Director of the UC Berkeley Center for the Science of Psychedelics. Khan shares his journey into the world of science and policymaking, beginning with science journalism and inspired by David Nutt’s famous ‘Equasy’ paper and subsequent firing for telling the truth. Realizing how strong the disconnect was […]

The post PT458 – When Science, Society, and Policy Collide appeared first on Psychedelics Today.

]]> PT456 – Moloch, Kairos, Extended-State DMT, and the Spider Queen https://psychedelicstoday.com/2023/10/31/pt456-alexander-beiner/ Tue, 31 Oct 2023 16:45:47 +0000 https://psychedelicstoday.com/?p=21156 In this episode, David interviews Alexander Beiner: an Executive Director of Breaking Convention; writer of The Bigger Picture substack; and author of The Bigger Picture: How Psychedelics Can Help Us Make Sense of the World. He tells his personal story and how his first psychedelic experience felt like a homecoming; discusses his Rebel Wisdom media […]

The post PT456 – Moloch, Kairos, Extended-State DMT, and the Spider Queen appeared first on Psychedelics Today.

]]> PT453 – Neuroplasticity, Individualized Integration, and Psychedelic Medicine – Israel 2024 https://psychedelicstoday.com/2023/10/20/pt453-katrin-preller-ph-d-dr-michael-mithoefer/ Fri, 20 Oct 2023 13:05:00 +0000 https://psychedelicstoday.com/?p=21044 In this episode, David interviews psychiatrist, main researcher behind the first US Phase II trial of MDMA-assisted psychotherapy, and Senior Medical Director at MAPS Public Benefit Corporation: Dr. Michael Mithoefer; and Research Group Lead at the University of Zurich, and Principal Clinical Biomarker Lead at Boehringer Ingelheim, Katrin Preller, Ph.D. Mithoefer, Preller (and David) are […]

The post PT453 – Neuroplasticity, Individualized Integration, and Psychedelic Medicine – Israel 2024 appeared first on Psychedelics Today.

]]> PT452 – Metaplasticity, Reopening Critical Periods, and Octopuses on MDMA https://psychedelicstoday.com/2023/10/17/pt452-gul-dolen/ Tue, 17 Oct 2023 17:33:36 +0000 https://psychedelicstoday.com/?p=20978 In this episode, Melanie Pincus, Ph.D. and Manesh Girn, Ph.D. once again take over hosting duties, this time interviewing Gül Dölen, MD, Ph.D.: Associate professor of Neuroscience and Neurology at the Johns Hopkins University, School of Medicine, and head of the Dölen lab. Dölen largely researches the neuroscience behind social behaviors and is most known […]

The post PT452 – Metaplasticity, Reopening Critical Periods, and Octopuses on MDMA appeared first on Psychedelics Today.

]]> PT450 – Dreams, Psychedelics, Symbolism, and Cockroaches https://psychedelicstoday.com/2023/10/12/pt450-mackenzie-amara-dr-ido-cohen/ Thu, 12 Oct 2023 16:58:22 +0000 https://psychedelicstoday.com/?p=20914 In this episode, Johanna interviews Jungian analyst-in-training, writer, researcher, 5Rhythms® teacher, and Vital graduate: Mackenzie Amara; and Vital instructor, clinical psychologist, and creator of our new course, “Illuminating the Hidden Self: Navigating the Jungian Shadow with Psychedelics“: Dr. Ido Cohen. This sequel to their fascinating discussion about shadow work earlier this year focuses on dreams, […]

The post PT450 – Dreams, Psychedelics, Symbolism, and Cockroaches appeared first on Psychedelics Today.

]]> PT444 – A Glimpse Into the Psychedelic Neuroscience Landscape https://psychedelicstoday.com/2023/09/22/pt444-melanie-pincus-ph-d-manesh-girn-ph-d/ Fri, 22 Sep 2023 13:00:00 +0000 https://psychedelicstoday.com/?p=20624 In this special episode, Melanie Pincus, Ph.D. and Manesh Girn, Ph.D., who joined David in episode 403 to discuss the launch of their new course, essentially interview each other. As the 2nd edition of their popular course, Psychedelic Neuroscience Demystified, begins on November 1, we wanted to give them a chance to highlight some of […]

The post PT444 – A Glimpse Into the Psychedelic Neuroscience Landscape appeared first on Psychedelics Today.

]]> PT440 – Coming Back to Stillness, Microdosing and Adaptogens, and What We Can Learn From Autism https://psychedelicstoday.com/2023/09/08/pt440-dr-joqueta-handy-phd-imd/ Fri, 08 Sep 2023 16:11:56 +0000 https://psychedelicstoday.com/?p=20476 In this episode, David interviews Dr. JoQueta Handy, Ph.D., IMD: speaker, author, educator, Natural Integrative Health Practitioner, and CEO and Chief Visionary of Brilliant Learning, Handy Wellness Center, and Brilliant Blends. She shares childhood memories of growing up on her Grandparents’ farm, where she developed a deep appreciation for nature, staring at the stars, and […]

The post PT440 – Coming Back to Stillness, Microdosing and Adaptogens, and What We Can Learn From Autism appeared first on Psychedelics Today.

]]> PT431 – The Concept of Integration and the Need for Evolving Protocols of Psychedelic Therapy https://psychedelicstoday.com/2023/08/11/pt431-matthew-w-johnson-ph-d/ Fri, 11 Aug 2023 17:33:23 +0000 https://psychedelicstoday.com/?p=20123 In this episode, Kyle interviews The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins, and renowned researcher of nearly 20 years: Matthew W. Johnson, Ph.D. Recorded in-person at MAPS’ Psychedelic Science after running an 8-hour workshop on psychedelic therapy for addiction treatment, Johnson was still happy to sit down with […]

The post PT431 – The Concept of Integration and the Need for Evolving Protocols of Psychedelic Therapy appeared first on Psychedelics Today.

]]> Exploring the Vast Potential of Psychedelic Medicine: A Physician’s Perspective on Allopathy, Virtual Community, and Clinical Research https://psychedelicstoday.com/2023/08/09/exploring-the-vast-potential-of-psychedelic-medicine-a-physicians-perspective-on-allopathy-virtual-community-and-clinical-research/ Wed, 09 Aug 2023 17:57:29 +0000 https://psychedelicstoday.com/?p=19984 Neurology physician Dr. Burton Tabaac’s interest in psychedelics began almost by accident. He happened upon the topic through a 2019 presentation during his fellowship training at the Johns Hopkins University School of Medicine – and may not have pursued a dedicated interest in the field if he hadn’t attended. “… In four years of medical […]

The post Exploring the Vast Potential of Psychedelic Medicine: A Physician’s Perspective on Allopathy, Virtual Community, and Clinical Research appeared first on Psychedelics Today.

]]> PT430 – Psychedelics for Eating Disorders, Davos’ House of Psychedelics, and The Future of the Synthesis Institute https://psychedelicstoday.com/2023/08/08/pt430-maya-albert/ Tue, 08 Aug 2023 18:49:13 +0000 https://psychedelicstoday.com/?p=20088 In this episode, Joe interviews Maya Albert: Co-Founder of the Psyched conference, and Director of Operations at Tabula Rasa Ventures and the Synthesis Institute. She shares her journey of how she became involved in the psychedelic space through her mother, and her personal experience as a patient in a clinical trial on psilocybin for the […]

The post PT430 – Psychedelics for Eating Disorders, Davos’ House of Psychedelics, and The Future of the Synthesis Institute appeared first on Psychedelics Today.

]]> PT428 – The Promise of MAPS’ Phase III Data, Psychedelics and Adolescents, and the Need for Honest Drug Education https://psychedelicstoday.com/2023/08/01/pt428-rick-doblin-ph-d/ Tue, 01 Aug 2023 17:22:13 +0000 https://psychedelicstoday.com/?p=19908 In this episode, recorded on the eve of MAPS’ Psychedelic Science 2023, Kyle interviews MAPS’ Founder and President, Rick Doblin, Ph.D. He begins with an overview of the fast-approaching (and largest ever) psychedelics conference, emphasizing its significant growth, many features, and bipartisan opening ceremony, then discusses MAPS’ soon-to-be-released confirmatory Phase III data on MDMA-assisted therapy […]

The post PT428 – The Promise of MAPS’ Phase III Data, Psychedelics and Adolescents, and the Need for Honest Drug Education appeared first on Psychedelics Today.

]]> PT426 – Making the Impossible Possible: Flow Hacking and Peak Performance Aging https://psychedelicstoday.com/2023/07/25/pt426-steven-kotler/ Tue, 25 Jul 2023 16:25:36 +0000 https://psychedelicstoday.com/?p=19518 In this episode, Joe interviews one of the world’s leading experts on human performance: New York Times bestselling author and Executive Director of the Flow Research Collective, Steven Kotler. Kotler’s work explores the neurobiology of peak human performance, flow states, and aging, and the concept of getting our biology to work for us rather than […]

The post PT426 – Making the Impossible Possible: Flow Hacking and Peak Performance Aging appeared first on Psychedelics Today.

]]> PT425 – The Transformative Potential of Psychedelics, Community, and Live Music https://psychedelicstoday.com/2023/07/21/pt425-dr-gabrielle-lehigh/ Fri, 21 Jul 2023 17:48:04 +0000 https://psychedelicstoday.com/?p=19380 In this episode, David interviews Dr. Gabrielle Lehigh: Co-Founder and Managing Director of Psychedelic Grad, a web-based community serving as an educational and career hub for up-and-coming psychedelic professionals; and the host of the related podcast, “Curious to Serious,” where she speaks with students and professionals about the path they took to land in the […]

The post PT425 – The Transformative Potential of Psychedelics, Community, and Live Music appeared first on Psychedelics Today.

]]> PT421 – The Impact of the Therapeutic Alliance on the Psychedelic Experience https://psychedelicstoday.com/2023/07/07/dr-roberta-murphy/ Fri, 07 Jul 2023 10:42:59 +0000 https://psychedelicstoday.com/?p=19041 In this episode, David interviews Dr. Roberta Murphy: training medical psychotherapist and member of the Imperial Centre for Psychedelic Research. This is a rare impromptu podcast, recorded about a half hour after David heard Murphy speaking on a panel at UK’s Breaking Convention conference. He asked her if she wanted to be on the podcast […]

The post PT421 – The Impact of the Therapeutic Alliance on the Psychedelic Experience appeared first on Psychedelics Today.

]]> PT419 – Ketamine-Assisted Therapy for Severe Alcohol Use Disorder https://psychedelicstoday.com/2023/06/27/pt419-professor-celia-morgan/ Tue, 27 Jun 2023 16:31:16 +0000 https://psychedelicstoday.com/?p=18863 In this episode, David interviews Professor Celia Morgan, Ph.D., who holds the Chair of Psychopharmacology and co-leads the Transdisciplinary Psychedelics Group at The University of Exeter. This was recorded on the dawn of UK’s Breaking Convention conference, where Morgan was speaking about the therapeutic potential of ketamine as well as the danger of people developing […]

The post PT419 – Ketamine-Assisted Therapy for Severe Alcohol Use Disorder appeared first on Psychedelics Today.

]]> PT418 – Psychedelic Morning Show #2 with Joe Moore and Anne Philippi https://psychedelicstoday.com/2023/06/23/pt418-psychedelic-morning-show-2-with-joe-moore-and-anne-philippi/ Fri, 23 Jun 2023 16:38:45 +0000 https://psychedelicstoday.com/?p=18823 In the second episode of our special, two-part series, the Psychedelic Morning Show, Joe Moore and Anne Philippi are live once again bright and early from Psychedelic Science 2023 in Denver. Listen to this podcast as they interview four guests working on the front lines of psychedelic research, law, and the treatment of chronic pain. […]

The post PT418 – Psychedelic Morning Show #2 with Joe Moore and Anne Philippi appeared first on Psychedelics Today.

]]> PT417 – Psychedelic Morning Show #1 with Joe Moore and Anne Philippi https://psychedelicstoday.com/2023/06/22/psychedelic-morning-show-1-with-joe-moore-and-anne-philippi/ Thu, 22 Jun 2023 21:15:38 +0000 https://psychedelicstoday.com/?p=18801 Psychedelics Today is reporting live this week from the industry event of the year, Psychedelic Science 2023 in Denver. Listen in to this podcast as our co-founder, Joe Moore, and New Health Club founder Anne Philippi hit the conference floor bright and early in the first episode of a special two-part series, the Psychedelic Morning […]

The post PT417 – Psychedelic Morning Show #1 with Joe Moore and Anne Philippi appeared first on Psychedelics Today.

]]> PT416 – A New Chapter for Johns Hopkins Psychedelic & Consciousness Research https://psychedelicstoday.com/2023/06/20/pt416-frederick-barrett/ Tue, 20 Jun 2023 14:43:31 +0000 https://psychedelicstoday.com/?p=18710 In this episode, David interviews Frederick Barrett, Ph.D.: cognitive neuroscientist, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, and now, Director of the Johns Hopkins Center for Psychedelic & Consciousness Research. With today’s news, Barrett officially takes over for the legendary Roland Griffiths, who has been in the role […]

The post PT416 – A New Chapter for Johns Hopkins Psychedelic & Consciousness Research appeared first on Psychedelics Today.

]]> PT412 – Psychedelics and Virtual Reality: Where Novel Experience, Technology, and Altered States of Consciousness Meet https://psychedelicstoday.com/2023/05/30/pt412-agnieszka-sekula-dr-prash-p/ Tue, 30 May 2023 19:18:55 +0000 https://psychedelicstoday.com/?p=18360 In this episode, Joe interviews the Co-Founders of Enosis Therapeutics: researcher and scientist, Agnieszka Sekula; and psychiatrist, clinical advisor to the Australian Psychedelic Society, and leading Australian advocate for psychedelic-assisted psychotherapy, Dr. Prash P.  Enosis Therapeutics is a medtech startup that began with the question: how can we use VR – with or without psychedelics […]

The post PT412 – Psychedelics and Virtual Reality: Where Novel Experience, Technology, and Altered States of Consciousness Meet appeared first on Psychedelics Today.

]]> Psychedelics Weekly – New LSD Research and The Challenges Facing a Rapidly Growing Psychedelic Guide Industry https://psychedelicstoday.com/2023/05/26/psychedelics-weekly-new-lsd-research-and-the-challenges-facing-a-rapidly-growing-psychedelic-guide-industry/ Fri, 26 May 2023 18:29:07 +0000 https://psychedelicstoday.com/?p=18336 In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous challenges facing the rapidly growing industry of psychedelic therapists, guides, and facilitators. That discussion comes from the article, “Psychedelic workers of the world, unite!”, which breaks down the shortcomings and risks of […]

The post Psychedelics Weekly – New LSD Research and The Challenges Facing a Rapidly Growing Psychedelic Guide Industry appeared first on Psychedelics Today.

]]> PT410 – Manufacturing MDMA and Why Creating MDMA Analogs Is So Important https://psychedelicstoday.com/2023/05/16/pt410-nick-kadysh/ Tue, 16 May 2023 17:52:28 +0000 https://psychedelicstoday.com/?p=18261 In this episode, Joe interviews Nick Kadysh: Founder and CEO of PharmAla Biotech and member of the board of directors for The Canadian Psychedelic Businesses Association.  PharmAla Biotech is a Toronto-based Life Sciences company with two focuses: contracting with manufacturers to provide researchers with GMP MDMA (created under Good Manufacturing Practice regulations), and creating and […]

The post PT410 – Manufacturing MDMA and Why Creating MDMA Analogs Is So Important appeared first on Psychedelics Today.

]]> The Psychedelic Mind: How Neuroscience Can Help You Navigate Your Inner Landscape https://psychedelicstoday.com/2023/04/27/the-psychedelic-mind-how-neuroscience-can-help-you-navigate-your-inner-landscape/ Thu, 27 Apr 2023 19:09:23 +0000 https://psychedelicstoday.com/?p=18053 Psychedelics are a fascinating class of compounds that have potent effects on our consciousness. After a multi-decade hiatus, scientific research on psychedelics has now resumed with full force. One field that has rapidly developed in recent years is psychedelic neuroscience, which applies the cutting-edge frameworks and tools of modern neuroscience to understand how psychedelics affect […]

The post The Psychedelic Mind: How Neuroscience Can Help You Navigate Your Inner Landscape appeared first on Psychedelics Today.

]]> PT405 – The Psychedelic Medicine PAC: The Push for Federal Funding and Politicians Who Will Fight for Us https://psychedelicstoday.com/2023/04/14/pt405-melissa-lavasani/ Fri, 14 Apr 2023 19:38:38 +0000 https://psychedelicstoday.com/?p=17855 In this episode, Joe interviews Melissa Lavasani: CEO of Washington, DC-based Psychedelic Medicine Coalition, and now, President of the brand new Psychedelic Medicine PAC. She discusses her path to psychedelics, how she ended up running the Initiative 81 campaign (the Entheogenic Plant and Fungus Policy Act of 2020), and how she came to realize that […]

The post PT405 – The Psychedelic Medicine PAC: The Push for Federal Funding and Politicians Who Will Fight for Us appeared first on Psychedelics Today.

]]> PT404 – Clusterbusters: The Horrors of Cluster Headaches and the Miracle of Psilocybin https://psychedelicstoday.com/2023/04/11/pt404-bob-wold-and-eileen-brewer/ Tue, 11 Apr 2023 20:04:15 +0000 https://psychedelicstoday.com/?p=17828 In this episode, Joe lets Court Wing take lead in interviewing two of the leaders behind Clusterbusters: Founder and Executive Director, Bob Wold; and President, Eileen Brewer. A long-time friend of the show, Court Wing has become our resident expert on chronic pain, writing articles about how psilocybin relieved his chronic pain, and hosting Timothy […]

The post PT404 – Clusterbusters: The Horrors of Cluster Headaches and the Miracle of Psilocybin appeared first on Psychedelics Today.

]]> PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified https://psychedelicstoday.com/2023/04/04/pt403-melanie-pincus-and-manesh-girn/ Tue, 04 Apr 2023 18:17:39 +0000 https://psychedelicstoday.com/?p=17661 In this episode, David interviews neuroscientist, artist, and educator, Melanie Pincus, Ph.D.; and Ph.D. candidate in Neuroscience, lead or co-author on over a dozen scientific publications, and regular contributor to PT, Manesh Girn.  They tell their stories of how they became interested in neuroscience, and stress the importance of staying radically open-minded (or “epistemically naive”) […]

The post PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified appeared first on Psychedelics Today.

]]> PT401 – The Self-Entropic Broadening Theory: Understanding The Psychedelic State and Psychosis https://psychedelicstoday.com/2023/03/28/pt401-haley-maria-dourron/ Tue, 28 Mar 2023 18:23:34 +0000 https://psychedelicstoday.com/?p=17581 In this episode, Joe interviews Ph.D. student in the Drug Use and Behavior Lab at the University of Alabama Birmingham, Haley Maria Dourron. She talks mostly about the paper she co-authored last year with Dr. Peter Hendricks and Camilla Strauss: “Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics […]

The post PT401 – The Self-Entropic Broadening Theory: Understanding The Psychedelic State and Psychosis appeared first on Psychedelics Today.

]]> Psychedelics Weekly – More Trouble For Field Trip Health, Ketamine Wellness Centers Abruptly Close, & The Creation of the Psychedelic Medicine PAC https://psychedelicstoday.com/2023/03/24/psychedelics-weekly-more-trouble-for-field-trip-health-ketamine-wellness-centers-abruptly-close-the-creation-of-the-psychedelic-medicine-pac/ Fri, 24 Mar 2023 20:25:42 +0000 https://psychedelicstoday.com/?p=17563 In this episode of Psychedelics Weekly, Joe and Kyle are back at it, talking about news and what’s going on at Psychedelics Today (applications for Vital close this Sunday, March 26, and we’ve just announced a new neuroscience course!). Following up on last week’s news that Field Trip Health had closed five clinics, they start […]

The post Psychedelics Weekly – More Trouble For Field Trip Health, Ketamine Wellness Centers Abruptly Close, & The Creation of the Psychedelic Medicine PAC appeared first on Psychedelics Today.

]]> PT400 – Beckley Retreats: Combining Modern Science, Tradition, and Holistic Wellness https://psychedelicstoday.com/2023/03/21/pt400-neil-markey/ Tue, 21 Mar 2023 17:35:54 +0000 https://psychedelicstoday.com/?p=17526 In this episode, Joe interviews the Co-Founder and CEO of Beckley Retreats, Neil Markey.  Markey describes Beckley Retreats as comprehensive well-being programs, and talks about the importance of holistic wellness – that, while the retreats are centered around two group psilocybin experiences, the true benefits come from complementary factors: the four weeks of online prep […]

The post PT400 – Beckley Retreats: Combining Modern Science, Tradition, and Holistic Wellness appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Drug-Free Digital Trips, The Prevalence of Challenging Experiences, and the End of Synthesis Institute https://psychedelicstoday.com/2023/03/10/psychedelics-weekly-drug-free-digital-trips-the-prevalence-of-challenging-experiences-and-the-end-of-synthesis-institute/ Fri, 10 Mar 2023 18:29:58 +0000 https://psychedelicstoday.com/?p=17387 In this episode of Psychedelics Weekly, David is joined by Kyle, who is finally home after a lot of traveling, to talk shop and dig into the articles they found the most interesting this week.  They begin with the news that Paul Stamets now has a species of mushroom named after him (Psilocybe stametsii), then […]

The post Psychedelics Weekly – Drug-Free Digital Trips, The Prevalence of Challenging Experiences, and the End of Synthesis Institute appeared first on Psychedelics Today.

]]> Mind the Gap: The Importance of Gender Equity in Psychedelic Clinical Trials https://psychedelicstoday.com/2023/03/07/mind-the-gap-the-importance-of-gender-equity-in-psychedelic-clinical-trials/ Tue, 07 Mar 2023 17:01:41 +0000 https://psychedelicstoday.com/?p=17289 Psychedelics, once heavily restricted for research, are now being rigorously tested through clinical trials to explore their potential therapeutic benefits. But how are women represented in the search to uncover the efficacy of psychedelic medicines? While the inclusion of women in psychedelic clinical trials is clearly important – both to understand the effects of these […]

The post Mind the Gap: The Importance of Gender Equity in Psychedelic Clinical Trials appeared first on Psychedelics Today.

]]> PT391 – MDMA-Assisted Psychotherapy For Fibromyalgia and Other Central Sensitization Syndromes https://psychedelicstoday.com/2023/02/21/pt391/ Tue, 21 Feb 2023 19:43:59 +0000 https://psychedelicstoday.com/?p=16844 In this episode, Joe interviews Dr. Devon Christie: Senior Lead of Psychedelic Programs at Numinus, educator at CIIS and Vital, and MAPS-certified MDMA therapist; and Dr. Pamela Kryskow, MD: founding board member of the Psychedelic Association of Canada and Medical Lead of the nonprofit, Roots To Thrive. Christie and Kryskow recently co-authored one of the […]

The post PT391 – MDMA-Assisted Psychotherapy For Fibromyalgia and Other Central Sensitization Syndromes appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin and the Immune System, & Canalization and Plasticity https://psychedelicstoday.com/2023/02/03/psychedelics-weekly-research-explained-ketamine-and-the-corticothalamic-network-psilocybin-and-the-immune-system-canalization-and-plasticity/ Fri, 03 Feb 2023 18:22:51 +0000 https://psychedelicstoday.com/?p=16521 In this episode of Psychedelics Weekly, the rest of the team is out or at Cannadelic, so a new voice steps up to the plate: Julian Bost, who works with the Vital team and handles the majority of our email, records his first podcast with Ph.D. candidate in Neuroscience, friend of the show, and speaker […]

The post Psychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin and the Immune System, & Canalization and Plasticity appeared first on Psychedelics Today.

]]> PT381 – DMT, Hierarchies of Complexity, and Reality Switch Technologies https://psychedelicstoday.com/2023/01/10/pt381/ Tue, 10 Jan 2023 17:05:09 +0000 https://psychedelicstoday.com/?p=15949 In this episode, Joe interviews Dr. Andrew R. Gallimore: computational neurobiologist, chemical pharmacologist, researcher, and writer of Alien Information Theory: Psychedelic Drug Technologies and the Cosmic Game. Gallimore feels that DMT is the most efficient and effective reality switching molecule we’ve seen, and that there is no other psychedelic experience that is so in your […]

The post PT381 – DMT, Hierarchies of Complexity, and Reality Switch Technologies appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize, and B.C.’s Decriminalization Experiment https://psychedelicstoday.com/2023/01/06/psychedelics-weekly-psilocybin-assisted-psychotherapy-for-i-b-s-ny-aims-to-legalize-and-b-c-s-decriminalization-experiment/ Fri, 06 Jan 2023 16:56:30 +0000 https://psychedelicstoday.com/?p=15904 In this week’s episode, Joe and David meet up to talk about Vital, Convergence, and the latest news:  -Tryp Therapeutics and Mass General signing a letter of intent for a Phase 2 clinical trial investigating the effects of psilocybin-assisted psychotherapy for the treatment of Irritable Bowel Syndrome – interesting because it further highlights the likely […]

The post Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize, and B.C.’s Decriminalization Experiment appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association Endorses Decriminalization, and Scott Wiener Introduces Senate Bill 58 https://psychedelicstoday.com/2022/12/30/psychedelics-weekly-psilocybin-and-stress-response-the-minnesota-medical-association-endorses-decriminalization-and-scott-wiener-introduces-senate-bill-58/ Fri, 30 Dec 2022 16:39:29 +0000 https://psychedelicstoday.com/?p=15828 In this week’s episode, Joe and Kyle are together again before Kyle sets off for a 2-month road trip centered around Vital retreats, where we hope he’ll be able to report in from live while in Jamaica.  They talk about Vital: applications are open for the April 2023 edition and close in February, so if […]

The post Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association Endorses Decriminalization, and Scott Wiener Introduces Senate Bill 58 appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics, and Could States Legalize by 2037? https://psychedelicstoday.com/2022/12/16/psychedelics-weekly-proposition-122-in-action-the-economics-of-psychedelics-and-could-states-legalize-by-2037/ Fri, 16 Dec 2022 14:58:03 +0000 https://psychedelicstoday.com/?p=15666 In this week’s episode, Joe and David team up again to discuss what news interested them the most this week: the DA dropping a felony drug charge against a mushroom rabbi in Denver due to the passing of Proposition 122; Numinus Submitting a Clinical Trial Application to Health Canada that would give in-training practitioners the […]

The post Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics, and Could States Legalize by 2037? appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Genetic Memory, “The Psychedelic Renaissance,” and Harm Reduction at Music Festivals https://psychedelicstoday.com/2022/12/09/psychedelics-weekly-genetic-memory-the-psychedelic-renaissance-and-harm-reduction-at-music-festivals/ Fri, 09 Dec 2022 16:30:00 +0000 https://psychedelicstoday.com/?p=15581 In this week’s episode, Joe and David team up for the first time to discuss three articles: Chacruna’s breakdown of the study, “Ceremonial Ayahuasca in Amazonian Retreats – Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study,” Double Blind’s “Why the ‘Psychedelic Renaissance’ is just Colonialism by Another Name,” and the results from the […]

The post Psychedelics Weekly – Genetic Memory, “The Psychedelic Renaissance,” and Harm Reduction at Music Festivals appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations https://psychedelicstoday.com/2022/12/02/psychedelics-weekly-cannabis-as-an-adjunct-cancer-treatment-5-meo-dmt-reactivations/ Fri, 02 Dec 2022 14:15:00 +0000 https://psychedelicstoday.com/?p=15452 In this week’s episode, Joe and Alexa talk about the excitement brewing around our first conference-meets-festival, Convergence (March 30 – April 2 at the Wisdome in LA), and some of the sponsorships starting to come in (interested? email Alexa@psychedelicstoday.com). Then, they dive into what intrigued them the most this week: a study looking into potentiality and […]

The post Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations appeared first on Psychedelics Today.

]]> PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home EEG Microdosing Study https://psychedelicstoday.com/2022/11/29/pt375/ Tue, 29 Nov 2022 19:46:57 +0000 https://psychedelicstoday.com/?p=15414 In this episode, Victoria hosts a bit of a microdosing roundtable, speaking with three champions of microdosing: “The Father of modern microdosing,” James Fadiman, Ph.D.; Adam Bramlage, Founder/CEO of Flow State Micro (a functional mushroom company and microdosing educational platform); and Conor Murray, Ph.D., a neuroscientist at UCLA who conducted the world’s first EEG microdosing […]

The post PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home EEG Microdosing Study appeared first on Psychedelics Today.

]]> Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain https://psychedelicstoday.com/2022/11/25/psychedelics-weekly-bipartisan-political-movement-psychedelics-and-pain/ Fri, 25 Nov 2022 17:40:50 +0000 https://psychedelicstoday.com/?p=15362 This week features David Drapkin, Joe Moore (for the first part), and introduces Alexa Jesse, who you’ve probably heard in ads, but who makes her first appearance on the podcast.  They discuss two big political moves in the advancement of psychedelics: the creation of the Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus (led by Representatives […]

The post Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain appeared first on Psychedelics Today.

]]> Why Did Psychedelics Relieve My Chronic Pain? https://psychedelicstoday.com/2022/11/18/why-did-psychedelics-relieve-my-chronic-pain/ Sat, 19 Nov 2022 00:37:50 +0000 https://psychedelicstoday.com/?p=15198 In part 2 of the article, “Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain,” the disappearance of Court’s chronic pain leads to a new understanding of cortical remapping, mirror box therapy, and how science can treat phantom limb pain. Immediate Changes Post-Dosing I had years of experience in cold water training from my Aikido […]

The post Why Did Psychedelics Relieve My Chronic Pain? appeared first on Psychedelics Today.

]]> Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain https://psychedelicstoday.com/2022/11/15/surprising-results-psilocybin-trial-for-depression-alleviates-chronic-pain/ Tue, 15 Nov 2022 21:08:07 +0000 https://psychedelicstoday.com/?p=15008 An NYU psilocybin depression study participant discovers an unforeseen application for psychedelics: the treatment of chronic pain. Part 1 of the series: Psychedelics and Chronic Pain. Everything Worked, but Nothing Lasted In the fall of 2020, I was living a pretty successful and happy life – on paper. I had co-founded a very popular, leading-edge […]

The post Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain appeared first on Psychedelics Today.

]]> PT372 – The Heroic Hearts Project: Veterans and The Impact of Storytelling https://psychedelicstoday.com/2022/11/11/pt372/ Fri, 11 Nov 2022 17:44:50 +0000 https://psychedelicstoday.com/?p=14956 Listen to this episode where Joe interviews Heroic Hearts Project Founder and President, Jesse Gould and Chief of Operations, Zach Riggle. They discuss the need for psychedelics and other therapies for veterans and their families suffering from military trauma.

The post PT372 – The Heroic Hearts Project: Veterans and The Impact of Storytelling appeared first on Psychedelics Today.

]]> PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer? https://psychedelicstoday.com/2022/11/01/pt369/ Tue, 01 Nov 2022 18:28:23 +0000 https://psychedelicstoday.com/?p=14711 Listen to this episode on how psychedelics could be the answer to chronic pain, featuring Founder of REMAP Therapeutics, Court Wing, and Drs. Joel Castellanos and Timothy Furnish of UC San Diego's Psychedelics and Health Research Initiative (PHRI).

The post PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer? appeared first on Psychedelics Today.

]]> PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules https://psychedelicstoday.com/2022/10/21/pt366/ Fri, 21 Oct 2022 16:14:36 +0000 https://psychedelicstoday.com/?p=14321 In this episode, Joe Moore interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle Hines, Ph.D. (also the CEO and an Associate Professor at UNLV), and Dr. Dustin Hines, Ph.D. (the CSO as well as an Assistant Professor at UNLV). While Tesselate's primary objective is the development of novel psychedelic molecules, the Hines' work goes much deeper than that, as they are researching the ways the brain communicates with itself and other parts of the body: how neurotransmitter systems interact, why synaptic partners find each other, and how certain substances may be able to modulate the actions of specific receptors. They talk about the reductionist base of neuroscience; the biodiversity in human populations and how heterogeneous depression can be; the structure of the cerebral cortex; neuroplasticity; the price of bringing new drugs to the FDA and the strategy of "failing fast," and much more.

The post PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules appeared first on Psychedelics Today.

]]> Inflammation Nation: How Psychedelics Could Combat Widespread Chronic Pain https://psychedelicstoday.com/2022/10/19/how-psychedelics-could-combat-chronic-pain/ Wed, 19 Oct 2022 20:28:00 +0000 https://psychedelicstoday.com/?p=13599 Could a nation defined by inflammation find relief in psychedelics? It’s a verifiable truth that the United States of America may be considered a global leader, especially when it comes to the prevalence of mental and physical health disorders. In fact, of the nearly 330 million people in the population, millions to hundreds of millions […]

The post Inflammation Nation: How Psychedelics Could Combat Widespread Chronic Pain appeared first on Psychedelics Today.

]]> PT334 – Prof. David Nutt – The Human Brain, Addiction, and Telling the Truth About Drugs https://psychedelicstoday.com/2022/07/05/pt334/ Tue, 05 Jul 2022 14:24:53 +0000 https://psychedelicstoday.com/?p=12673 In this episode, David Drapkin interviews David Nutt: Psychiatrist, Founder and Chief Scientific Officer at Drug Science, Chief Research Officer at Awakn Life Sciences, and Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Imperial College London. After a successful study on MDMA in the treatment of alcohol use disorder, Nutt is looking into if improvements can be made to MDMA. He discusses how serotonin seems to affect the default mode network; Robin Carhart-Harris’ “Trial of Psilocybin versus Escitalopram for Depression" study and the realization that psychedelics were doing something different in the brain; Measure 109 and the importance of how Oregon establishes a new paradigm around legal mushrooms; drug hysteria in the US and UK and how drastically that differs from Portugal's incredibly successful approach to drugs; why real world evidence is the core of science; and why psychedelics seem best at disrupting internalizing disorders.

The post PT334 – Prof. David Nutt – The Human Brain, Addiction, and Telling the Truth About Drugs appeared first on Psychedelics Today.

]]> PT333 – Miriam Volat, MS & T. Cody Swift, MFT – Conservation, Peyote, and Indigenous Biocultural Survival https://psychedelicstoday.com/2022/07/01/pt333/ Fri, 01 Jul 2022 15:58:43 +0000 https://psychedelicstoday.com/?p=12640 In this episode, Joe Moore interviews Co-Directors of The Riverstyx Foundation: Miriam Volat, MS, and T. Cody Swift, MFT. They cover several important topics related to Indigenous cultural survival, plant medicine biocultures, medicine conservation and sustainable propagation, and the work they do through Riverstyx, the Indigenous Peyote Conservation Initiative (ICPI) and the Indigenous Medicine Conservation Fund as a means to promote philanthropy and integrity within the psychedelic space.

The post PT333 – Miriam Volat, MS & T. Cody Swift, MFT – Conservation, Peyote, and Indigenous Biocultural Survival appeared first on Psychedelics Today.

]]> PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics https://psychedelicstoday.com/2022/06/28/pt332/ Tue, 28 Jun 2022 14:23:42 +0000 https://psychedelicstoday.com/?p=12594 In this episode of the podcast, Joe Moore interviews the CEO of Mindset Pharma, James Lanthier. Mindset Pharma is a 3-year old biotechnology company built on discovering and developing new psychedelic compounds to be used as medicine for a variety of indications. While the efficacy of the psychedelics we know can’t be denied, the goal of science is to improve, and Lanthier believes optimizing these drugs will make them safer, more predictable, and more palatable for a far greater portion of the population. Lanthier discusses what’s going on at Mindset Pharma; why patents alone will not be sufficient protection from competition; the long game of biotech, psychedelic stocks, and overreaction to slow growth; the Nagoya protocol; mescaline; the need for big pharma and capitalism; the art of formulation; and how microdosing could soon be revolutionized.

The post PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics appeared first on Psychedelics Today.

]]> PT330 – Dick Simon – Researching Ethnobotanical Efficacy and the Search For New Therapeutic Molecules https://psychedelicstoday.com/2022/06/21/pt330/ Tue, 21 Jun 2022 21:02:20 +0000 https://psychedelicstoday.com/?p=12529 In this episode, Joe interviews the Co-Founder and CEO of Sensorium Therapeutics, Dick Simon. Sensorium was created to fully research plants and fungi that already have established efficacy – their goal being to have the largest collection of psychoactive plants, to use machine learning to figure out exactly which molecules are doing what, to then synthesize new drugs that are safe and effective, and eventually bring these new compounds through the FDA approval process. Simon talks about how so much of what we know to be effective and beneficial is based on assumptions or best guesses, and while that doesn't discredit very real benefits, it does beg the question: Is this all optimized as best as it could be? He also discusses how recent advances in neuroscience and technology are catalyzing molecular research; the benefits and challenges of nutraceuticals; geopolitical conflict resolution; the challenges of benzodiazepines; and the problem with people needing to be treatment-resistant or seriously ill to gain access to psychedelics. He hopes that what Sensorium Therapeutics learns over the coming years will help bring better medicines to more people.

The post PT330 – Dick Simon – Researching Ethnobotanical Efficacy and the Search For New Therapeutic Molecules appeared first on Psychedelics Today.

]]> PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine https://psychedelicstoday.com/2022/06/14/rick-doblin-phd/ Tue, 14 Jun 2022 13:50:27 +0000 https://psychedelicstoday.com/?p=12444 In this episode, David Drapkin interviews Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), Rick Doblin, Ph.D. MAPS has recently been at the center of media scrutiny, notably through New York magazine's “Cover Story” podcast series, which chronicled instances of alleged sexual abuse within the MAPS clinical MDMA trials. We wanted to provide an opportunity for Doblin to respond to these very real concerns, and he does just that, discussing how MAPS reacted; what could have been done better; what this has all meant for MAPS; and how it feels to suddenly be seen by many as an enemy in a space they helped build. He also discusses what the post-approval psychedelic landscape could look like; their goals for facilitator training and how they align with requirements in Oregon; their desire for a patient registry or “global trauma index”; and the importance of collecting and analyzing real-world evidence. And he talks about MAPS and their globalization goals: how exploring psychedelic therapy specifically in countries with little to no tradition of psychotherapy can lead to new therapeutic models.

The post PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine appeared first on Psychedelics Today.

]]> PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and A Deeper Relationship With Plants https://psychedelicstoday.com/2022/06/03/pt324/ Fri, 03 Jun 2022 13:52:31 +0000 https://psychedelicstoday.com/?p=12340 In this episode of the podcast, Joe Moore interviews cannabis expert and social ethnobotanist, Amanda Reiman, Ph.D., MSW. Reiman is the Founder of Personal Plants; an organization dedicated to promoting a deeper relationship between people and plants, and Co-Founder of Sacred Garden; a Web3 project which advocates for entheogenic plant conservation. She discusses the early days of growing cannabis; the pros and cons of pharmaceutical vs. herbal plant models; the rules around cannabis regulation and taxes; how the different consumption patterns of cannabis and psychedelics could lead to vastly different pharmaceutical models; and what she'd like to do to promote a better connection to plants: guided tours of sacred gardens in virtual reality. She discusses the endless possibilities of cryptocurrencies, NFTs, and other Web3 projects, and wonders if defense funds and clinical trials could soon be entirely crowd-funded and therefore taken out of the hands of venture capitalists and the government.

The post PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and A Deeper Relationship With Plants appeared first on Psychedelics Today.

]]> PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted Psychotherapy, Therapist Burnout, and LSD for Anxiety https://psychedelicstoday.com/2022/05/31/pt323/ Tue, 31 May 2022 13:42:40 +0000 https://psychedelicstoday.com/?p=12300 In this episode of the podcast, Kyle Buller interviews Dr. Reid Robison and Steve Thayer, Ph.D. of Novamind, and hosts of the Psychedelic Therapy Frontiers podcast. Robison and Thayer talk about their work with ketamine-assisted psychotherapy (KAP); their combined efforts with Numinus Wellness to scale psychedelic therapy accessibility; the nuance of ketamine treatment; how ketamine can be used for therapist burnout; the benefits of group ketamine sessions; the inner healer; and the platform of standards and training they are currently building at Novamind.

The post PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted Psychotherapy, Therapist Burnout, and LSD for Anxiety appeared first on Psychedelics Today.

]]> PT315 – Dr. Dominique Morisano – From Research to Reality: Planning a Global Psychedelic Summit https://psychedelicstoday.com/2022/05/03/pt315/ Tue, 03 May 2022 15:02:28 +0000 https://psychedelicstoday.com/?p=12052 In this episode of the podcast, David Drapkin interviews Dr. Dominique Morisano: clinical psychologist, professor, researcher, and Co-Founder of the upcoming non-profit conference, "From Research to Reality: Global Summit on Psychedelic-Assisted Therapies and Medicine." Three years in the making and planned as a one-time event, Morisano considers the conference to be a state of the union of the field of psychedelic science, where people from all fields in psychedelia will meet and discuss what we know, what the future could look like, and how we can get there. Each presentation was submitted and reviewed by a committee of peers, and will largely feature new research. The conference is May 27th to May 29th in Toronto, and a virtual option is available, with a special "Saturday night special" featuring David Nutt, Rick Doblin, Monnica Williams, and others.

The post PT315 – Dr. Dominique Morisano – From Research to Reality: Planning a Global Psychedelic Summit appeared first on Psychedelics Today.

]]> PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere https://psychedelicstoday.com/2022/04/22/pt312/ Fri, 22 Apr 2022 12:30:00 +0000 https://psychedelicstoday.com/?p=11901 In this Earth Day episode of the podcast, Joe Moore interviews publisher, ecologist, planetary steward, and co-owner of Synergetic Press, Deborah Snyder. The two cover a wide range of ecology-based topics like earth as a biosphere, the environmental ecological engineering project Biosphere 2, the importance of thinking in whole systems, and how psychedelics play a role in our understanding of the complex, organic living systems we live in.

The post PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere appeared first on Psychedelics Today.

]]> PT296 – Dr. David Luke – Vital Psychedelic Conversations https://psychedelicstoday.com/2022/02/25/pt296/ Fri, 25 Feb 2022 14:00:00 +0000 https://psychedelicstoday.com/?p=11271 In this episode of Vital Psychedelic Conversations, Kyle Buller interviews researcher, author, Associate Professor of Psychology at the University of Greenwich, and Co-Founder and Director of the Breaking Convention conference: Dr. David Luke. Luke talks about the importance of understanding the full range of psychedelic experiences; the difficulty in defining and measuring the transpersonal, how science has pathologized (and religion has demonized) the weird; and the need for counselors to be open minded to the reality (and after effects) of their clients' experiences. And he talks about DMT and entity encounters: Why do people who have these experiences have such massive shifts in belief afterward? What are these entities? While he can't answer these questions, he shares a few stories of his own that led to prolonged, incremental ontological shock in his own life.

The post PT296 – Dr. David Luke – Vital Psychedelic Conversations appeared first on Psychedelics Today.

]]> PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy https://psychedelicstoday.com/2022/02/22/pt295/ Tue, 22 Feb 2022 14:00:00 +0000 https://psychedelicstoday.com/?p=11177 In this episode of the podcast, Joe Moore interviews Professor of Neuroscience, author, and Founder and Vice Director of the Brain Institute at Universidade Federal do Rio Grande do Norte in Brazil: Sidarta Ribeiro. Ribeiro talks about what he's seeing happen in psychiatry: that we're realizing how little traditional psychiatry paid attention to set and setting, how much the creation and spread of antidepressants was influenced by conflicts of interest, and how the future of psychiatry and psychotherapy will mean more talking and less use of drugs (and not the other way around). He also discusses dreams and his book, “The Oracle of Night: The History and Science of Dreams”; research where MDMA was given to octopuses; how we're arriving at many "new" conclusions that are actually old; why he's primarily researching LSD; the ayahuasca-like drink, jurema; how we need to look at things outside the realm of logical positivism; microdosing; biopiracy; and how we actually have the ability to collectively solve most of humanity’s problems but don’t due to greed.

The post PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy appeared first on Psychedelics Today.

]]> PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic Conversations https://psychedelicstoday.com/2022/02/18/pt294/ Fri, 18 Feb 2022 14:00:00 +0000 https://psychedelicstoday.com/?p=11153 In this episode of Vital Psychedelic Conversations, David Drapkin interviews Andrew Tatarsky, Ph.D.; author and developer of Integrative Harm Reduction Psychotherapy, and Juliana Mulligan; writer and head of Inner Vision Ibogaine. Both are part of The Center for Optimal Living in NYC (CFOL); Tatarsky as the Founder and Director, and Mulligan as the Psychedelic Program Coordinator. They talk about reframing addiction, the ways society divides us by accepted behaviors, how being taught to doubt ourselves as children creates trauma, the idea of the "disease narrative" and self-demonization, how research studies support the idea of the quick fix, and harm reduction as a pathway to a better self.

The post PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic Conversations appeared first on Psychedelics Today.

]]> PT292 – Sam Gandy – Vital Psychedelic Conversations https://psychedelicstoday.com/2022/02/11/pt292/ Fri, 11 Feb 2022 14:00:00 +0000 https://psychedelicstoday.com/?p=11061 In this episode of Vital Psychedelic Conversations, Kyle Buller interviews Sam Gandy: researcher, science writer, Ph.D. ecologist, and collaborator with the Centre for Psychedelic Research at Imperial College London who is most interested in the capacity of psychedelics to amplify or ignite our relationship with nature. He talks about David Luke's study on nature interconnectedness after psychedelic experiences and ways to add nature into the integration and prep stages, from VR to planting seeds to even just looking at pictures or videos. He talks about the challenge of maximizing the benefits of the psychedelic experience and the need for more knowledge on how to integrate, asking how we can also use psychedelics intentionally as creativity-enhancing agents (analyzing James Fadiman and Willis Harman’s 1966 "Selective Enhancement of Specific Capacities Through Psychedelic Training" study).

The post PT292 – Sam Gandy – Vital Psychedelic Conversations appeared first on Psychedelics Today.

]]> PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations https://psychedelicstoday.com/2022/01/28/pt288/ Fri, 28 Jan 2022 14:00:00 +0000 https://psychedelicstoday.com/?p=10894 In this episode of the podcast, Kyle sits down for the 2nd edition of Vital Psychedelic Conversations; this week with Annie & Michael Mithoefer, who are best known for groundbreaking trials they've been involved in, including two MAPS-sponsored Phase II trials studying MDMA-assisted therapy for PTSD, a study providing MDMA-assisted sessions to therapists completing the MAPS therapist training, and a pilot study treating couples with MDMA-assisted therapy combined with Cognitive Behavioral Conjoint Therapy. They discuss why they connected so much with breathwork; what trusting the process means (for the patient and facilitator); the concept of inner healing capacity; how the communal, group process aspect of breathwork is inspiring ideas for group MDMA sessions; updates on new trials for 2022; their best advice and biggest takeaways they've learned from decades in the field, and more!

The post PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations appeared first on Psychedelics Today.

]]> PT283 – Greg McKee – Nociplastic Pain and Psychedelics https://psychedelicstoday.com/2022/01/11/greg-mckee/ Tue, 11 Jan 2022 14:00:00 +0000 https://psychedelicstoday.com/?p=10684 In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company focusing on nociplastic pain and how it could be alleviated through the brain rewiring often possible in the psychedelic experience. They are first looking at psychedelics for chronic pain and eating disorders, and when this podcast was recorded, had just received FDA clearance to begin a fibromyalgia study at the University of Michigan (with studies on phantom limb pain, complex regional pain syndrome, binge eating disorder, and hypothalamic obesity likely coming after). McKee discusses the origins of Tryp, the benefits of using synthetics, the positives to take away from Compass Pathways' preliminary psilocybin Phase 2B trial results, and why a lot of early psychedelic investors may be mistakenly panicking.

The post PT283 – Greg McKee – Nociplastic Pain and Psychedelics appeared first on Psychedelics Today.

]]> PTSF89 – A Macro Dive Into Microdosing https://psychedelicstoday.com/2021/12/17/macro-dive-into-microdosing/ Fri, 17 Dec 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10471 In this week's Solidarity Fridays episode, inspired by their conversation with James Fadiman from a few weeks ago, Joe Moore and Kyle Buller dive into all things microdosing: Why people are doing it, what they're using, possible negative effects, how it could work with pain (pain management and/or neurogenesis), what other indications it could help, what other life variables are at play when microdosing, and how the classic self-blinding study that many deemed the death knell for microdosing should actually be seen as the beginning of a long road of research. Joe then shares an Instagram post from author Kelly Starrett that sarcastically showcases the problems with physical therapy in a careless healthcare system, which leads to a conversation about how one decides what a good outcome is in mental health therapy.

The post PTSF89 – A Macro Dive Into Microdosing appeared first on Psychedelics Today.

]]> PTSF88 – Dr. Ben Sessa of Awakn Life Sciences + Josh Bartch of Mydecine Innovations Group https://psychedelicstoday.com/2021/12/10/ptsf88/ Fri, 10 Dec 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10417 In this week's Solidarity Fridays episode, David Drapkin first interviews psychiatrist, researcher, drug policy reform advocate, and Co-founder and Chief Medical Officer of Awakn Life Sciences, Dr. Ben Sessa. They discuss their frustration with the current maintenance-medication state of psychiatry and addiction treatment, drug policy in the UK, and the impressive results from the world’s first MDMA-assisted psychotherapy study to treat alcohol-use disorder. Then, in part 2, David and Kyle Buller speak with Director, CEO, and Chairman of Mydecine Innovations Group, Josh Bartch. Bartch discusses Mydecine’s compound, MYCO-001, which will be used in the first NIDA-funded study in nearly 50 years: a smoking cessation study headed up by Dr. Matthew Johnson. He discusses their app, Mindleap Health; the amazing efficacy of psilocybin on smoking cessation; microdosing; and the importance he places on reframing how psychedelics are viewed in order to inspire greater public adoption.

The post PTSF88 – Dr. Ben Sessa of Awakn Life Sciences + Josh Bartch of Mydecine Innovations Group appeared first on Psychedelics Today.

]]> PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves https://psychedelicstoday.com/2021/11/30/james-fadiman-phd/ Tue, 30 Nov 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10326 In this episode, Joe Moore and Kyle Buller finally interview legendary author and microdosing popularizer, James Fadiman, Ph.D. He talks about the birth and emergence of transpersonal psychology, the early days of the Transpersonal Association and their relationship with Ram Dass, and getting LSD from Sandoz Pharmaceuticals and the vastly different ways people started experimenting with it. He discusses microdosing: how it emerged, dosing amounts, how you're supposed to feel, and the recent self-blinding microdose study and how he thinks the "not statistically significant" results were actually pretty notable. And he talks about his newest book, Your Symphony of Selves: Discover and Understand More of Who We Are, which he sums up quite well with: "Have you ever argued with yourself? Who is the other person arguing?" He believes that we are made up of several different shifting selves and the key to a happy and healthy life is to embody the right self at the right time.

The post PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves appeared first on Psychedelics Today.

]]> PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus https://psychedelicstoday.com/2021/11/26/ptsf86/ Fri, 26 Nov 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10305 In this week's Solidarity Fridays episode, Joe Moore and David Drapkin interview Numinus Co-founder and CEO, Payton Nyquvest. Joe and Kyle Buller first discuss upcoming courses, Wonderland, Covid, whether or not psychedelics are in an "ivory tower,” and Mike Tyson: his insistence on saying "toad" and his relationship to Gerry Sandoval. Then, Joe and David speak with Payton Nyquvest of Numinus, a company that offers ketamine-assisted psychotherapy and features Numinus Biosciences, which recently produced the first legal psilocybin product derived from natural psilocybin-producing mushrooms. Nyquvest discusses how his mother's substance abuse recovery and a trip to an ayahuasca retreat center taught him how to reimagine his chronic pain as a gift, psilocybin, and more.

The post PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus appeared first on Psychedelics Today.

]]> PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of Wesana Health https://psychedelicstoday.com/2021/11/19/ptsf85/ Fri, 19 Nov 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10250 In this week's Solidarity Fridays episode, we’re featuring two shorter interviews, recorded in a media room at the Wonderland Miami conference last week: CEO & Director of BetterLife Pharma, Ahmad Doroudian, Ph.D., and Chief Medical Officer at Wesana Health, Dr. Abid Nazeer.
Doroudian discusses the non-hallucinogenic compound, 2-Bromo-LSD. While the LSD we know and love has shown great signs at being effective for the treatment of cluster headaches, many people (including Doroudian) do not want to experience the hallucinatory part of this medicine, so BetterLife Pharma has been researching using this LSD relative to address this very need (and it may be even safer than LSD too).

Part 2 of this split podcast features David Drapkin sitting down with Chief Medical Officer at Wesana Health, Abid Nazeer, who talks about opening the first ketamine clinic in the midwest, the need for integrative wellness, and traumatic brain injuries, which they're researching alongside MAPS. He talks about what he wants to do with Wesana Health, which is essentially creating a "center of excellence" hub where a patient can be referred to different departments (spokes) specializing in any number of possible healing modalities, all under the same network.

The post PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of Wesana Health appeared first on Psychedelics Today.

]]> PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences https://psychedelicstoday.com/2021/11/16/pt273/ Tue, 16 Nov 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10191 In this episode, Joe Moore interviews Erica Rex: writer and participant in one of the first ever clinical trials using psilocybin to treat cancer-related depression. She talks about her complicated path to becoming part of the study, the study itself, and how integral communication, community, and integration were toward her healing. And she tells 3 different stories of spontaneous mystical experiences; tears in the fabric of her universe where the lines between reality and dreams were blurred, including one where a friend's deceased mother (who she had never met) spoke to her in a dream about her own family. This leads to a discussion about the DSM, psychiatry, and how we don't know anywhere near enough about schizophrenia or these strange brushes with the mystical.

The post PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences appeared first on Psychedelics Today.

]]> PTSF84 – A Brief Check-in From Wonderland https://psychedelicstoday.com/2021/11/12/ptsf84/ Fri, 12 Nov 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10174 In this week's Solidarity Fridays episode, Joe Moore and Kyle Buller recorded together from a hotel in Biscayne Bay, looking out over Miami Beach and reflecting over the Wonderland Miami conference they just attended. And that's what this abbreviated podcast is: a quick check-in to discuss Wonderland (and Meet Delic, which Joe attended) while it's all still fresh in their minds. Beyond the reviews and comparisons, they talk about how it felt to attend a big conference again; Joe's panel about what the world of psychedelics will look like in ten years; Compass Pathways' just-released research outcomes and why Joe is reconsidering his critiques of their patent issues; and how a few of the people they met at Wonderland are already motivating them and making them consider just how much they can really do with Psychedelics Today.

The post PTSF84 – A Brief Check-in From Wonderland appeared first on Psychedelics Today.

]]> PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers https://psychedelicstoday.com/2021/11/09/pt271/ Tue, 09 Nov 2021 14:00:00 +0000 https://psychedelicstoday.com/?p=10125 In this episode, Joe Moore and Kyle Buller interview famed anthropologist and author (most notably of The Cosmic Serpent), Jeremy Narby. He is also the Amazonian projects director for Nouvelle Planète, a nonprofit organization that promotes the economic and cultural empowerment of Indigenous peoples through demarcation of land. Narby talks about how Humphry Osmond and political anthropology led him to psychedelics, and how he realized people in the states had started speaking highly of the ecological knowledge of Indigenous people of the Amazon without ever talking about the hallucinogenic way they attained that knowledge (and how he felt it was his place to start talking about it). He also discusses anthropology and subjectivity; Richard Evans Schultes; the problem with trying to substantiate hallucinations; the West's focus on “the active ingredient” and how ayahuasca is much more than drinkable DMT; the overuse and microdosing of ayahuasca; the entourage effect and how it's excluded by the "DMT explains everything" hypothesis; why vine-only ayahuasca needs to be researched more; and the differences in how people react to LSD vs. ayahuasca or psilocybin (do the natural drugs have a trickster spirit in them that doesn't like some people?).

The post PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers appeared first on Psychedelics Today.

]]> PT270 – Dr. Rachel Yehuda – Research Trials and The Future of Psychedelic Neuroscience https://psychedelicstoday.com/2021/11/05/pt270/ Fri, 05 Nov 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=10095 In this episode, Joe Moore interviews Dr. Rachel Yehuda: neuroscientist, researcher, Professor and Vice Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai, and Director of Mental Health at the James J. Peters VA Medical Center. Dr. Yehuda talks about the importance and complications of research trials: the difficulty researchers have in remaining neutral; how protocols have an arbitrary beginning and end that may not make sense to the participant; how the process of getting funding for one’s own clinical trial begins with creating a specific protocol; and how, while it can often feel like therapy for participants, the purpose of these trials is often more for researchers to learn from participants how to better run the trials themselves. And she discusses her background and path to psychedelic research, why knowing the pharmacology of a compound doesn’t explain enough, what she thinks the next few years of psychedelic neuroscience looks like, how to work with big corporations who may seem like they're only in it for the money, and how we need a science to predict and analyze who will or won't respond to a particular treatment (and why).

The post PT270 – Dr. Rachel Yehuda – Research Trials and The Future of Psychedelic Neuroscience appeared first on Psychedelics Today.

]]> PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and Future https://psychedelicstoday.com/2021/10/12/pt266/ Tue, 12 Oct 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9914 In today's episode, Kyle Buller interviews anthropologist, author, ethnomycologist, and now co-designer of the new Psychedelics Today course (beginning October 26th), "Psychedelics: Past, Present, and Future": Jerry B. Brown, Ph.D. This podcast serves as a brief overview of what the course goes much further into, from the landmark psychedelic events that brought us here, the current models of psychedelic-assisted therapy, and the many career avenues that have opened up (and will continue to open up) as a result of this renaissance. He discusses Albert Hofmann's synthesis of LSD, Stan Grof's first psilocybin experience, the Nixon administration and the beginnings of the drug war, Roland Griffiths and Walter Pahnke (and Rick Doblin's follow-up research), the early end-of-life cancer and psilocybin study, the creation of the Mystical Experience Questionnaire, the concerns over Compass Pathways and patent law, and how Gordon Watson's betrayal of María Sabina mirrors a lot of what's going on today between Indigenous tradition and the Western money grab. And he gives a very detailed description of his life-changing psilocybin journey that led him to the discovery of his soul's code.

The post PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and Future appeared first on Psychedelics Today.

]]> PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs https://psychedelicstoday.com/2021/10/05/pt265/ Tue, 05 Oct 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9824 In this episode, Joe Moore interviews Jessica Cadoch, MA: Medical Anthropologist, former Executive Director of the Montreal Psychedelic Society, and current Research Manager working at Maya Public Benefit Corporation. She talks about her psychedelic path and two most important pieces of research: First, how the rites of passage one experiences at a psytrance festival emulates the traditional ritual structure, and second; the concerns for people in long-term recovery and 12-step programs using substances therapeutically, for getting off their problematic substances, and even recreationally (when those substances have been labelled “dangerous drugs” their whole lives). She discusses Maya, a platform where psychedelic therapists can gain better insights into their practices by learning from one another's reports, developing more consistent protocols, and creating better qualitative questions and measures for patients. And she talks about a lot more: how people view different substances based on if they're man-made or not, spiritual bypassing, Carl Hart and the dangers of drug exceptionalism, the need to decriminalize all drugs, 12-step programs and the risks of 13th steppers, how our culture views medicine as gospel, and how we all need to stop the in-fighting and division within our psychedelic communities and learn to work with the big corporations many are scared of.

The post PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs appeared first on Psychedelics Today.

]]> Meet Microdosing TikTok—And Why the Community Matters https://psychedelicstoday.com/2021/09/22/meet-microdosing-tiktok-why-the-community-matters/ Wed, 22 Sep 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9630 Original Illustration by Martin Clarke Microdosing TikTok is a vibrant community of everyday people researching and experimenting with microdosing for mental health, and finding support in the process. What if I told you that the microdosing movement has taken TikTok by storm? Or that TikTok wasn’t just a place for dancing or kids, but a […]

The post Meet Microdosing TikTok—And Why the Community Matters appeared first on Psychedelics Today.

]]> PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and Creativity https://psychedelicstoday.com/2021/08/17/pt258/ Tue, 17 Aug 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9286 In this episode, Kyle Buller and Michelle Janikian interview return guest, Manesh Girn: Ph.D. candidate in Neuroscience at McGill University and co-author of over a dozen scientific publications, most recently on the neurocognitive processes behind creative thinking and the potentiality for psychedelics to enhance creativity. Girn explains neuroplasticity and how it relates to the default-mode, salience, and other networks; how his paper maps the similarities between psychedelic mindstates, dream states, and different types of thought; the distinctions between objective, subjective, spontaneous, and deliberate creativity; the difference between psychological and cognitive flexibility; how it's an oversimplification to so strongly attribute ego dissolution to default-mode network interconnectivity, how psilocybin affected people’s creativity and perceived insightfulness in a recent study inspired by his paper, and more! While many episodes of Psychedelics Today are either science or philosophy-heavy, this episode is a great mixture of both.

The post PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and Creativity appeared first on Psychedelics Today.

]]> PTSF71 – Sexual Ethics in Psychedelics and Mistrust of Big Pharma https://psychedelicstoday.com/2021/08/06/ptsf71/ Fri, 06 Aug 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9227 In this week's Solidarity Fridays episode, Joe Moore and Kyle Buller discuss psychedelic research company, Numinus, being granted approval by Health Canada to study MDMA-assisted therapy. And later, they discuss Michael Pollan's books, opium, and mescaline. And they report on the launch of The Psychae Institute, a $40m psychedelic medicine institute in Melbourne that will be studying MDMA and likely DMT (which would somehow only be the second study?!). But most of this episode centers around two topics that keep coming up: first, sexual ethics and power dynamics within the facilitator-experiencer relationship, and second: why do we mistrust big corporations and big pharma so much, when many of us can thank them for saving our lives? This leads down many roads: Peter Thiel, Fauci, SB-519 possession limits, the social contract, why lying is sometimes necessary, and more!

The post PTSF71 – Sexual Ethics in Psychedelics and Mistrust of Big Pharma appeared first on Psychedelics Today.

]]> PT256 – Matthew D. Segall, Ph.D. – Consciousness, Capitalism, and Philosophy https://psychedelicstoday.com/2021/08/03/pt256/ Tue, 03 Aug 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9167 In this episode, Joe Moore interviews philosopher, author, and assistant professor in the Philosophy, Cosmology, and Consciousness program at California Institute of Integral Studies in San Francisco: Matthew D. Segall, Ph.D. They discuss the relationship between consciousness and neuroscience and how science, philosophy, and religion need to focus on their specialties but also work together towards better defining the human experience. They also talk about the importance of philosophy in trying to make sense of non-ordinary states of consciousness, William James, Richard Dawkins, scientism, positivism, how we're slowly thinning the line between technology and humanity, Timothy Leary and whether or not anyone really "dropped out," German idealism, how capitalism co-opts everything, the death denial in capitalist life, and how to use the relationship between the internet and capitalism to improve society.

The post PT256 – Matthew D. Segall, Ph.D. – Consciousness, Capitalism, and Philosophy appeared first on Psychedelics Today.

]]> PTSF69 – Well-being and Working With Weirdness https://psychedelicstoday.com/2021/07/23/ptsf69/ Fri, 23 Jul 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=9075 In this week's Solidarity Fridays episode, Joe Moore and David Drapkin review the news and have a discussion on cynicism, mysticism, and well-being. They first look at Senate Bill 519 again and wonder if we, as a subculture, have become too cynical in how we view progress. And they discuss an article stressing the need to acknowledge and attempt to study the mystical part of psychedelics, a study that measured improvements in well-being and the difficulty in defining such an open concept, Kabbalah, permaculture, Ethan Roland’s concept of 8 forms of capital, and more!

The post PTSF69 – Well-being and Working With Weirdness appeared first on Psychedelics Today.

]]> PTSF68 – Neuroplasticity, Michael Pollan, and DMT, with Manesh Girn https://psychedelicstoday.com/2021/07/16/ptsf68/ Fri, 16 Jul 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=8988 In this week's Solidarity Friday episode, Joe Moore, Michelle Janikian, Kyle Buller, and David Drapkin are joined by Ph.D. candidate in Neuroscience at McGill University, Manesh Girn, to review last week’s article about psilocybin inducing "rapid and persistent" growth in the dendritic spines of mice. Girn explains what dendritic spines, "learned helplessness,” elevated excitatory neurotransmission, and “head twitch response” all mean. They also review Michael Pollan's recent op-ed about how we should do drugs, Senate Bill 519's progress and missteps, the normalization of DMT, and more!

The post PTSF68 – Neuroplasticity, Michael Pollan, and DMT, with Manesh Girn appeared first on Psychedelics Today.

]]> PT253 – Sean Hinton Ph.D. – Culture, Research Limitations, and Non-Medical Paths Forward https://psychedelicstoday.com/2021/07/13/pt253/ Tue, 13 Jul 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=8944 In this episode, Joe Moore interviews psychologist and adjunct professor at Capella University, Dr. Sean Hinton.

Hinton talks about his early days at the Institute of Transpersonal Psychology, how so many current research studies just reinforce what we already know or want to further prove, Timothy Leary and his cultural, non-medicalized approach, and much more. And he asks: How do we view integration outside the medical model?
How do we view these tools anthropologically and sociologically and keep them from being solely medicalized?

The post PT253 – Sean Hinton Ph.D. – Culture, Research Limitations, and Non-Medical Paths Forward appeared first on Psychedelics Today.

]]> Dissociation as Medicine? Exploring Dissociation & Dissociative Psychedelics like Ketamine https://psychedelicstoday.com/2021/07/12/dissociation-dissociative-drugs-ketamine-explainer/ Mon, 12 Jul 2021 14:51:14 +0000 https://psychedelicstoday.com/?p=8835 By Rebecca Martinez How do you draw the line between a healthy escape and a dissociative disorder? And could dissociative psychedelics like ketamine play a part? We live in a deeply interconnected world. From our ecosystems to our societies, the Earth is made up of living things held in dynamic relationships. We as humans are […]

The post Dissociation as Medicine? Exploring Dissociation & Dissociative Psychedelics like Ketamine appeared first on Psychedelics Today.

]]> PTSF67 – Psilocybin, Power, and Patents https://psychedelicstoday.com/2021/07/09/ptsf67/ Fri, 09 Jul 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=8889 In this week's Solidarity Friday episode, Joe Moore, Michelle Janikian, Kyle Buller, and newest Psychedelics Today team member, David Drapkin, talk about a recent psilocybin for depression study, the DEA fighting the Right to Try Act, and the story of Sha'Carri Richardson and Biden’s refusal to pay attention to the realities of the drug war. They also discuss IP, patent law, peyote, and SSRIs.

The post PTSF67 – Psilocybin, Power, and Patents appeared first on Psychedelics Today.

]]> Book Review: Alexander Shulgin’s The Nature of Drugs https://psychedelicstoday.com/2021/06/23/book-review-alexander-shulgin-the-nature-of-drugs/ Wed, 23 Jun 2021 18:43:06 +0000 https://psychedelicstoday.com/?p=8648 By Lex Pelger A review of The Nature of Drugs: History, Pharmacology, and Social Impact (Synergetic Press, 2021), a collection of eight lectures given by the “godfather of ecstasy” Dr. Alexander Shulgin. And so begins one of the best classes you’ll ever take… “Most of you have already been exposed to drugs, and most of […]

The post Book Review: Alexander Shulgin’s The Nature of Drugs appeared first on Psychedelics Today.

]]> PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity https://psychedelicstoday.com/2021/05/25/pt245-robin-carhart-harris-psychedelics-entropy-and-plasticity/ Tue, 25 May 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=8339 In this episode, Michelle and Kyle interview head of the Centre for Psychedelic Research at Imperial College London, Founding Director of the new Neuroscape Psychedelics Division at UCSF, and psychedelic research legend, Robin Carhart-Harris.  He discusses what inspired his milestone entropic brain/REBUS model research and how psychedelics drop the assuredness we’ve established through our “prediction […]

The post PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity appeared first on Psychedelics Today.

]]> PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge https://psychedelicstoday.com/2021/05/14/ptsf59/ Fri, 14 May 2021 13:00:00 +0000 https://psychedelicstoday.com/?p=8234 In this week’s Solidarity Fridays episode, Michelle, Kyle, and Joe welcome Benjamin Mudge to talk about psychedelics and bipolar disorder, and although there was an intention to also cover some news, the bipolar topic turned out to be quite interesting- so much so that there will need to be a part 2 of this episode […]

The post PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge appeared first on Psychedelics Today.

]]>